BioLife Solutions, Inc.
BLFS
$35.07
-$0.16-0.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.45% | 24.69% | 63.91% | 31.21% | 18.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.45% | 24.69% | 63.91% | 31.21% | 18.88% |
| Cost of Revenue | 24.09% | 37.91% | 107.77% | 37.11% | 26.04% |
| Gross Profit | 20.03% | 18.22% | 45.59% | 28.09% | 15.36% |
| SG&A Expenses | -2.41% | 6.81% | 2.37% | 23.40% | 17.02% |
| Depreciation & Amortization | 137.88% | 28.79% | 103.69% | 2.34% | -90.34% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.34% | 21.82% | 70.56% | 29.10% | 14.38% |
| Operating Income | 380.33% | 105.41% | -114.76% | 78.71% | 53.68% |
| Income Before Tax | 118.12% | 337.89% | 312.58% | 227.59% | -173.34% |
| Income Tax Expenses | -33,711.90% | 342.86% | -820.83% | 202.50% | 12,500.00% |
| Earnings from Continuing Operations | 394.39% | 337.64% | 373.71% | 231.85% | -175.56% |
| Earnings from Discontinued Operations | -- | -- | -25.41% | -- | 96.59% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 384.78% | 364.73% | -11.16% | 136.47% | 23.56% |
| EBIT | 380.33% | 105.41% | -114.76% | 78.71% | 53.68% |
| EBITDA | 3,531.51% | 6,500.00% | -77.47% | -34.39% | -106.91% |
| EPS Basic | 378.52% | 357.89% | -13.93% | 135.23% | 26.42% |
| Normalized Basic EPS | 718.60% | 504.17% | 298.41% | 222.67% | 121.29% |
| EPS Diluted | 374.59% | 310.53% | -13.94% | 127.10% | 26.42% |
| Normalized Diluted EPS | 711.63% | 521.74% | 304.92% | 220.00% | 121.29% |
| Average Basic Shares Outstanding | 2.24% | 2.81% | 3.21% | 3.79% | 3.90% |
| Average Diluted Shares Outstanding | 3.13% | 1.82% | 2.03% | 5.52% | 3.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |